These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38369337)

  • 1. Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
    Nasu H; Nishio S; Park J; Tasaki K; Terada A; Tsuda N; Kawano K; Kojiro-Sanada S; Akiba J; Ushijima K
    Kurume Med J; 2024 May; 69(3.4):237-249. PubMed ID: 38369337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma.
    Lu S; Shi J; Zhang X; Kong F; Liu L; Dong X; Wang K; Shen D
    Virchows Arch; 2021 Nov; 479(5):893-903. PubMed ID: 33817764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
    Jung H; Bae GE; Kim HM; Kim HS
    Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
    Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
    Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target.
    Yang J; Peng Y; Ding Y; Liu Y; Wang Y; Liu Y; Liu C
    Mod Pathol; 2024 Oct; 37(10):100569. PubMed ID: 39025403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
    Nishio S; Mikami Y; Tokunaga H; Yaegashi N; Satoh T; Saito M; Okamoto A; Kasamatsu T; Miyamoto T; Shiozawa T; Yoshioka Y; Mandai M; Kojima A; Takehara K; Kaneki E; Kobayashi H; Kaku T; Ushijima K; Kamura T
    Gynecol Oncol; 2019 Apr; 153(1):13-19. PubMed ID: 30709650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
    Selenica P; Alemar B; Matrai C; Talia KL; Veras E; Hussein Y; Oliva E; Beets-Tan RGH; Mikami Y; McCluggage WG; Kiyokawa T; Weigelt B; Park KJ; Murali R
    Mod Pathol; 2021 Jun; 34(6):1213-1225. PubMed ID: 33318584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
    Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
    Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional Direct Smear Yields Diagnostic Indicators of Gastric-Type Mucinous Carcinoma Compared with Cytomorphological Features Identified by Liquid-Based Cervical Cytology.
    Ryu A; Nagata S; Kubo C; Ueda Y; Tanada S; Idota A; Kamiura S; Honma K; Yamasaki T
    Acta Cytol; 2021; 65(2):150-157. PubMed ID: 33176300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
    Ross JS; Wang K; Gay L; Otto GA; White E; Iwanik K; Palmer G; Yelensky R; Lipson DM; Chmielecki J; Erlich RL; Rankin AN; Ali SM; Elvin JA; Morosini D; Miller VA; Stephens PJ
    JAMA Oncol; 2015 Apr; 1(1):40-49. PubMed ID: 26182302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
    Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ
    Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
    Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
    Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
    Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
    Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
    Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.